Phase II Study of Cabozantinib in Recurrent/Metastatic Merkel Cell Carcinoma Exelixis

  • Rabinowits, Guilherme (PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date1/1/14 → 1/1/19

Funding

  • National Comprehensive Cancer Network (NCCN): $168,500.00